Short-term induction of thrombocytopenia delays periodontal healing in rats with periodontal disease: Participation of endostatin and vascular endothelial growth factor

Journal of Periodontal Research

Volumn 45, Issue 2, 2010, Pages 184-192

  Spolidorio, L C ^a   Herrera, B S ^b   Coimbra, L S ^a   Figueiredo, M N ^a   Spolidorio, D M P ^a   Muscara M N ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endostatin; Periodontal healing; Platelet; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC PROTEIN; ANTISERUM; ENDOSTATIN; PEROXIDASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ALVEOLAR BONE LOSS; ANGIOGENESIS; ANIMAL; ARTICLE; BLOOD; BONE REGENERATION; BONE REMODELING; COMPARATIVE STUDY; IMMUNOLOGY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PERIODONTITIS; PHYSIOLOGY; RABBIT; RAT; SPRAGUE DAWLEY RAT; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TIME; WOUND HEALING;

ALVEOLAR BONE LOSS; ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; BLOOD PLATELETS; BONE REGENERATION; BONE REMODELING; ENDOSTATINS; IMMUNE SERA; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PERIODONTITIS; PEROXIDASE; PLATELET COUNT; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; THROMBOCYTOPENIA; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 77950233379     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2009.01216.x     Document Type: Article

References (54)

1. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003, 82:82-90.
2. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Madzarevic M, Kenney EB. Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res 2002, 37:300-306.
3. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25.
4. Larrivee B, Karsan A. Signaling pathways induced by vascular endothelial growth factor (review). Int J Mol Med 2000, 5:447-456.
5. Cetinkaya BO, Keles GC, Ayas B, Sakallioglu EE, Acikgoz G. The expression of vascular endothelial growth factor in a rat model at destruction and healing stages of periodontal disease. J Periodontol 2007, 78:1129-1135.
6. Ma L, Elliott SN, Cirino G, Buret A, Ignarro LJ, Wallace JL. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci USA 2001, 98:6470-6475.
7. Linder BL, Chernoff A, Kaplan KL, Goodman DS. Release of platelet-derived growth factor from human platelets by arachidonic acid. Proc Natl Acad Sci USA 1979, 76:4107-4111.
8. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998, 275:H1054-H1061.
9. Von Hundelshausen P, Weber KS, Huo Y. Deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001, 103:1718-1720.
10. Ma L, Hollenberg MD, Wallace JL. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist. Br J Pharmacol 2001, 134:701-704.
11. Ma L, Del Soldato P, Wallace JL. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: shifting the angiogenic balance. Proc Natl Acad Sci USA 2002, 99:13243-13247.
12. Ma L, Mcknight W, Dicay M, Klein A, Hollenberg MD, Wallace JL. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci USA 2005, 102:216-220.
13. Wallace JL, Dicay M, McKnight W, Dudar GK. Platelets accelerate gastric ulcer healing through presentation of vascular endothelial growth factor. Br J Pharmacol 2006, 148:274-278.
14. Szabo S, Vincze A. Growth factors in ulcer healing: lessons from recent studies. J Physiol 2000, 94:77-81.
15. O'reilly MS, Boehm T, Shing Y. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
16. Roy H, Bhardwaj S, Ylä-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006, 580:2879-2887.
17. Rehn M, Veikkola T, Kukk-Valdre E. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001, 98:1024-1029.
18. Zohar R, Tenenbaum HC. How predictable are periodontal regenerative procedures? J Can Dent Assoc 2005, 71:675-680.
19. Carlson NE, Roach RB. Platelet-rich plasma: clinical applications in dentistry. J Am Dent Assoc 2002, 133:1383-1386.
20. Holzhausen M, Rossa Junior C, Marcantonio Junior E, Nassar PO, Spolidorio DM, Spolidorio LC. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 2002, 73:1030-1036.
21. Merhi Y, Provost P, Guidoin R, Latour JG. Importance of platelets in neutrophil adhesion and vasoconstriction after deep carotid arterial injury by angioplasty in pigs. Arterioscler Thromb Vasc Biol 1997, 17:1185-1191.
22. Rousseau G, Hebert D, Libersan D, Khalil A, St-Jean G, Latour JG. Importance of platelets in myocardial injury after reperfusion in the presence of of residual coronary stenosis in dogs. Am Heart J 1993, 125:1553-1563.
23. Merhi Y, Lam JYT, Lacoste LL, Latour JG, Guidoin R, Waters D. Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. Arterioscler Thromb Vasc Biol 1993, 13:951-957.
24. Okamura Y, Takeoka S, Teramura Y. Hemostatic effects of fibrinogen γ-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo. Transfusion 2005, 45:1221-1228.
25. Tamagawa-Mineoka R, Katoh N, Ueda E, Takenaka H, Kita M, Kishimoto S. The role of platelets in leukocyte recruitment in chronic contact hypersensivity induced by repeated elicitation. Am J Pathol 2007, 170:2019-2029.
26. Cenac N, Coelho A, Nguyen C. Induction of intestinal inflammation in mouse by activation of Proteinase-Activated Receptor-2. Am J Pathol 2002, 161:1903-1915.
27. Cetinkaya BO, Acikgoz G, Ayas B, Aliyev E, Sakallioglu EE. Increased expression of vascular endothelial growth factor in cyclosporin A-induced gingival overgrowth in rats. J Periodontol 2006, 77:54-60.
28. Ogawa K, Hori M, Tako R, Sakurada T. Effects of combined elcatonin alendronate treatment on the architecture, strength of bone in ovariectomized rats. J Bone Miner Metab 2005, 23:351-358.
29. Wada C, Kataoka M, Seto H. High-turnover osteoporosis is induced by cyclosporin A in rats. J Bone Miner Metab 2006, 24:199-205.
30. Spolidorio LC, Nassar PO, Nassar CA, Spolidorio DMP, Muscara MN. Conversion of immunossupressive monotherapy fromj cyclosporin A to tacrolimus improves alveolar bone loss in rats. Calcif Tissur Int 2007, 81:114-123.
31. Parfitt AM. Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system). Bone 1998, 9:67-69.
32. Johnson RB, Serio FG, Dai X. Vascular endothelial growth factors and progression of periodontal diseases. J Periodontol 1999, 70:848-852.
33. Steinberg AD, Alves ME, Lipowski J, Lebreton GC. Platelet association with gingival tissue inflammation. J Periodontol 1995, 66:860-863.
34. Papapanagiotou D, Nicu EA, Bizzarro S. Periodontitis is associated with platelet activation. Atherosclerosis 2009, 202(2):605-611.
35. Nassar CA, Nassar PO, Abrirached RSG, Holzhausen M, Marcantonio Júnior E, Spolidorio LC. Effect of cyclosporin A on alveolar boné homeostasis in a rat periodontitis model. J Periodontal Res 2004, 39:143-148.
36. Holzhausen M, Spolidorio LC, Vergnolle N. Proteinase-activated receptor-2 (PAR) agonist causes 2 periodontitis in rats. J Dent Res 2005, 84:154-159.
37. Graves DT, Fine D, Teng Y-TA, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host-bacteria interactions related to periodontal diseases. J Clin Periodontol 2008, 35:89-105.
38. Dennison DK, Van Dyke TE. The acute inflammatory response and the role of phagocytic cells in periodontal health and disease. Periodontology 2000 1997, 14:54-78.
39. Geerts SO, Nys M, De MP. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 2002, 73:73-78.
40. Forner L, Nielsen CH, Bendtzen K, Larsen T, Holmstrup P. Increased plasm a levels of IL-6 in bacteremic periodontis patients after scaling. J Clin Periodontol 2006, 33:724-729.
41. D'Aiuto F, Parkar M, Nibali L. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 2006, 151:977-984.
42. Paraskevas KI, Toli K, Poulakou MV. Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment? Expert Opin Ther Targets 2008, 12:1209-1215.
43. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 2002, 22:913-922.
44. Lourbakos A, Yuan YP, Jenkins AL. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood 2001, 15:97.
45. Suthin K, Matsushita K, Machigashira M. Enhanced expression of vascular endothelial growth factor by periodontal pathogens in gingival fibroblasts. J Periodontal Res 2003, 38:90-96.
46. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 1998, 94:395-404.
47. Cooke JW, Sarment DP, Whitesman LA. Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng 2006, 12:1441-1450.
48. Arayatrakoollikit U, Pavasant P, Yongchaitrakul T. Thrombin induces osteoprotegerin synthesis via phosphatidylinositol 3′-kinase/mammalian target of rapamycin pathway in human periodontal ligament cells. J Periodontal Res 2008, 43:537-543.
49. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest 1999, 103:879-887.
50. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature 2000, 407:258-264.
51. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Löwik CW. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000, 141:1667-1674.
52. Güneri P, Unlü F, Yeşilbek B. Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. J Periodonto 2004, 75:91-97.
53. Sakallioĝlu EE, Aliyev E, Lütfioĝlu M, Yavuz U, Açikgöz G. Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients. Clin Oral Investig 2007, 11:115-120.
54. Gujral DM, Bhattacharyya S, Hargreaves P, Middleton GW. Periodontal disease in a patient receiving Bevacizumab: a case report. J Med Case Reports 2008, 13:1-3.